Literature DB >> 23814741

Primary urachal mucinous adenocarcinoma of the urinary bladder.

Iqbal Singh1, Ravi Prasad.   

Abstract

Urinary bladder cancer is the second most frequent tumour of the genitourinary tract with bladder adenocarcinoma comprising for about 0.5-2% of all malignant bladder tumours. Other primary sites for such tumours include rectum, stomach, endometrium, breast, prostate, seminal vesicles and ovaries. Such non-urothelial bladder tumours with intramural bladder tumour growth may delay the onset of symptoms which may lead to a delay in the diagnosis and thereby adversely affecting the prognosis as compared to urothelial bladder tumours. Traditionally bladder adenocarcinomas were believed to be resistant to both chemotherapy and radiotherapy, but recent advancements have shown encouraging responses with adjuvant chemotherapy and radiotherapy. We present here a case of primary urachal mucinous adenocarcinoma of the urinary bladder highlighting their relative rarity of occurrence and the difficulties encountered in diagnosing primary bladder mucinous adenocarcinoma.

Entities:  

Keywords:  Adenocarcinoma urinary bladder; Cancer bladder; Urachal adenocarcinoma

Year:  2013        PMID: 23814741      PMCID: PMC3681068          DOI: 10.7860/JCDR/2013/5597.2973

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Urachal adenocarcinoma in situ with pseudomyxoma peritonei: a case report.

Authors:  G Stenhouse; D McRae; A M Pollock
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

2.  Primary adenocarcinoma of the urinary bladder: a single site analysis of 21 cases.

Authors:  Hu Zhang; Haowen Jiang; Zhong Wu; Zujun Fang; Jie Fan; Qiang Ding
Journal:  Int Urol Nephrol       Date:  2012-10-06       Impact factor: 2.370

3.  Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.

Authors:  H L Wang; D W Lu; L M Yerian; N Alsikafi; G Steinberg; J Hart; X J Yang
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

4.  Primary signet ring cell carcinoma of the bladder: a report on 10 cases.

Authors:  S Holmäng; G Borghede; S L Johansson
Journal:  Scand J Urol Nephrol       Date:  1997-04

5.  Signet-ring cell carcinoma arising from the urinary bladder.

Authors:  Imre Romics; Eszter Székely; Attila Szendroi
Journal:  Can J Urol       Date:  2008-10       Impact factor: 1.344

Review 6.  Urachal adenocarcinoma: a clinician's guide for treatment.

Authors:  Arlene Siefker-Radtke
Journal:  Semin Oncol       Date:  2012-10       Impact factor: 4.929

7.  Primary mucinous adenocarcinoma of the bladder with signet-ring cells: case report.

Authors:  Marcelo Lorenzi Marques; Gabriel Salum D'Alessandro; Daher Cezar Chade; Valéria Pereira Lanzoni; Samuel Saiovici; Cláudio José Ramos de Almeida
Journal:  Sao Paulo Med J       Date:  2007-09-06       Impact factor: 1.044

Review 8.  Primary signet ring cell carcinoma of the urinary bladder. Review of the literature and report of two cases.

Authors:  T Erdoğru; I Kiliçaslan; T Esen; H Ander; O Ziylan; V Uysal
Journal:  Urol Int       Date:  1995       Impact factor: 2.089

Review 9.  Signet-ring cell adenocarcinoma of bladder.

Authors:  L Fiter; F Gimeno; L Martin; L Gómez Tejeda
Journal:  Urology       Date:  1993-01       Impact factor: 2.649

Review 10.  Primary signet-ring cell carcinoma of the urinary bladder.

Authors:  Shusuke Akamatsu; Akira Takahashi; Masaaki Ito; Keiji Ogura
Journal:  Urology       Date:  2009-10-12       Impact factor: 2.649

View more
  2 in total

1.  Unusual presentation of urachal adenocarcinoma with genitourinary cutaneous metastasis.

Authors:  Yin-Hui Yang; Yan Zhu; Xiang-Wei Zhu; Hong-Juan Tang; Jian-Guo Hou; Wan-Hai Xu
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

2.  Urachal adenocarcinoma: a rare case report.

Authors:  Bo Bao; Muhammed Hatem; Jason K Wong
Journal:  Radiol Case Rep       Date:  2016-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.